Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors | springermedizin.de

Springer Medizin

nach oben

Clinical and Experimental Nephrology

Erschienen in:

13.11.2018 | Original article

Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors

verfasst von: Yoshito Yamaguchi, Fuyuko Akagaki, Aya Nakamori, Toshihiro Sugiura

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal resistive index (RI) calculated using renal Doppler ultrasonography (RDU) has recently been considered a clinically important indicator of renal outcome, survival, and systemic arteriosclerotic disorders. However, the cause of RI elevation remains unclear. The present study was an effort to first, identify the factors related to RI elevation, and second, understand the effect of renin-angiotensin system inhibitors (RAS-Is) on renal RI elevation.

Methods

We carried out this single-center case-control study among 100 CKD patients, recruited from outpatients who underwent RDU more than twice, at least a year apart. The rate of renal RI change per year (dRIpy) was chosen as the dependent variable: [(last examined renal RI—initial examined renal RI)/(initial examined renal RI × period of observation) × 100 (%/year)]. We examined the association between dRIpy and other clinical and biological data.

Results

Among 100 CKD patients, the average serum creatinine and eGFR were 1.76 ± 0.84 mg/dL and 37.0 ± 18.2 ml/min/1.73 m², respectively. The average dRIpy in all patients was 1.8 ± 1.4%/year. The linear multiple regression demonstrated that dRIpy was positively associated with the presence of diabetes mellitus (DM) and high low-density lipoprotein cholesterol (LDL) levels, and negatively with eGFR and RAS-I use.

Conclusions

This study demonstrated that the elevation of RI was related to DM, eGFR, high LDL, and the use of RAS-Is. In particular, RAS-Is could contribute towards suppressing the elevation of RI in CKD patients and towards preventing the development of renal failure in CKD patients.

Anzeige

1.

Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. Clin Exp Nephrol. 2011;15:114–20.CrossRefPubMed

2.

Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease. Nephrol Dial Transplant. 2009;24:2780–5.CrossRefPubMed

3.

Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension. 2002;39:699–703.CrossRefPubMed

4.

Okura T, Watanabe S, Miyoshi K, Fukuoka T, Higaki J. Intrarenal and carotid hemodynamics in patients with essential hypertension. Am J Hypertens. 2004;17:240–4.CrossRefPubMed

5.

Komuro K, Yokoyama N, Shibuya M, et al. Associations between increased renal resistive index and cardiovascular events. J Med Ultrason. 2016;V43:263–70.CrossRef

6.

Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int. 2005;68:878–8.CrossRefPubMed

7.

Kawai T, Kamide K, Onishi M, et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrol Dial Transplant. 2011;26:3256–62.CrossRefPubMed

8.

Calabia J, Torguet P, Garcia I, et al. The relationship between renal resistive index, arterial stiffness, and atherosclerotic burden: the link between macrocirculation and microcirculation. J Clin Hypertens (Greenwich). 2014;16:186–91.CrossRef

9.

Kintis K, Tsioufis C, Kasiakogias A, et al. Noninvasive assessment of haemodynamics in resistant hypertension: the role of the renal resistive index. J Hypertens. 2017;35:578–84.CrossRefPubMed

10.

Krumme B, Grotz W, Kirste G, Schollmeyer P, Rump LC. Determinants of intrarenal Doppler indices in stable renal allografts. J Am Soc Nephrol. 1997;8:813–6.PubMed

11.

Keogan MT, Kliewer MA, Hertzberg BS, DeLong DM, Tupler RH, Carroll BA. Renal resistive indexes: variability in Doppler US measurement in a healthy population. Radiology. 1996;199:165–9.CrossRefPubMed

12.

Buscemi S, Verga S, Batsis JA, et al. Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Res Clin Pract. 2009;86:177–85.CrossRefPubMed

13.

Geraci G, Mulè G, Mogavero M, Geraci C, Nardi E, Cottone S. Association between uric acid and renal hemodynamics: pathophysiological implications for renal damage in hypertensive patients. J Clin Hypertens (Greenwich). 2016;18:1007–14.CrossRef

14.

Boeri D, Derchi LE, Martinoli C, et al. Intrarenal arteriosclerosis and impairment of kidney function in NIDDM subjects. Diabetologia. 1998;41:121–4.CrossRefPubMed

15.

Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32–8.CrossRefPubMed

16.

Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4:643–6.CrossRefPubMedPubMedCentral

17.

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:6–20.CrossRef

18.

Eibenberger K, Schima H, Trubel W, Scherer R, Dock W, Grabenwöger F. Intrarenal Doppler ultrasonography: which vessel should be investigated? J Ultrasound Med. 1995;14:451–5.CrossRefPubMed

19.

Japanese Society of Neohrology. Evidence-based Clinical Practice Guideline for CKD 2018. Tokyo: Tokyo igakusya; 2018. (in Japanese).

20.

Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.CrossRefPubMed

21.

Mancini M, Masulli M, Liuzzi R, et al. Renal duplex sonographic evaluation of type 2 diabetic patients. J Ultrasound Med. 2013;32:1033–40.CrossRefPubMed

22.

Sari A, Dinc H, Zibandeh A, Telatar M, Gümele HR. Value of resistive index in patients with clinical diabetic nephropathy. Invest Radiol. 1999;34:718–21.CrossRefPubMed

23.

Matsumoto N, Ishimura E, Taniwaki H, et al. Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure. Nephron. 2000;86:44–51.CrossRefPubMed

24.

Brito PL, Fioretto P, Drummond K, et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int. 1998;53:754–61.CrossRefPubMed

25.

Lane PH, Steffes MW, Fioretto P, Mauer SM. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int. 1993;43:661–7.CrossRefPubMed

26.

Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FI. Clinical and histological correlations of decline in renal-function in diabetic-patients with proteinuria. Diabetes. 1994;43:1046–51.CrossRefPubMed

27.

Mise K, Hoshino J, Ueno T, et al. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. Diabetes Metab Res Rev. 2015;31:572–81.CrossRefPubMed

28.

Sugiura T, Nakamori A, Wada A, Fukuhara Y. Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular diseases. Clin Nephrol. 2004;61:119–26.CrossRefPubMed

29.

Boddi M, Cecioni I, Poggesi L, et al. Renal resistive index early detects chronic tubulointerstitial nephropathy in normo- and hypertensive patients. Am J Nephrol. 2006;26:16–21.CrossRefPubMed

30.

Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res. 2008;31:433–41.CrossRefPubMed

31.

Tsai CW, Ting IW, Yeh HC, et al. Longitudinal change in estimated GFR among CKD patients: a 10-year follow-up study of an integrated kidney disease care program in Taiwan. PLoS One. 2017;12:e0173843.CrossRefPubMedPubMedCentral

32.

Baba M, Shimbo T, Horio M, et al. Longitudinal study of the decline in renal function in healthy subjects. PLoS One. 2015;10:e0129036.CrossRefPubMedPubMedCentral

33.

Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed

34.

Derchi LE, Leoncini G, Parodi D, et al. Mild renal dysfunction and renal vascular resistance in primary hypertension. Am J Hypertens. 2005;18:966–71.CrossRefPubMed

35.

Imano H, Noda H, Kitamura A, et al. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med. 2011;52:381–6.CrossRefPubMed

36.

Geraci G, Mulè G, Mogavero M, et al. Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function. Nutr Metab Cardiovasc Dis. 2015;25:160–6.CrossRefPubMed

37.

Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease study. Kidney international. 1997;51:1908–19.CrossRefPubMed

38.

Rahman M, Yang W, Akkina S, et al. Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study. Clin J Am Soc Nephrol. 2014;9:1190–8.CrossRefPubMedPubMedCentral

39.

Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58:839–46.CrossRefPubMed

40.

Tublin ME, Tessler FN, Murphy ME. Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. Radiology. 1999;213:258–64.CrossRefPubMed

41.

Mills CJ, Gabe IT, Gault JH, et al. Pressure-flow relationships and vascular impedance in man. Cardiovasc Res. 1970;4:405–17.CrossRefPubMed

42.

O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200–4.CrossRefPubMed

43.

Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20:1–17.CrossRefPubMed

44.

Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17:17–25.CrossRef

45.

Mori T, Polichnowski A, Glocka P, et al. High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol. 2008;19:1472–82.CrossRefPubMedPubMedCentral

46.

ACCORD Study Group. Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362: 1575–85.CrossRef

47.

Berl T, Hunsicker LG, Lewis JB, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170–9.CrossRefPubMed

48.

Reynolds JC, Salcido DD, Menegazzi JJ. Coronary perfusion pressure and return of spontaneous circulation after prolonged cardiac arrest. Prehosp Emerg Care. 2010;14:78–84.CrossRefPubMedPubMedCentral

49.

Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15:1974–82.CrossRefPubMed

50.

SPRINT Research Group. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373: 2103–16.CrossRef

51.

Cheung AK, Rahman M, Reboussin DM, et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28:2812–23.CrossRefPubMedPubMedCentral

52.

Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000;35:60–6.CrossRefPubMed

53.

Derosa G, Maffioli P, Ferrari I, et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens Res. 2011;34:145–51.CrossRefPubMed

54.

Tiryaki O, Usalan C, Buyukhatipoglu H, Sayiner ZA, Kilisli H. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients. Clin Exp Hypertens. 2012;34:145–52.CrossRefPubMed

55.

Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Gotoh A, Uchida K, Higaki J. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension. Clin Exp Hypertens. 2006;28:451–61.CrossRefPubMed

56.

Caruso D, D‘Avino M, Acampora C, et al. Effects of losartan and chlorthalidone on blood pressure and renal vascular resistance index in non-diabetic patients with essential hypertension and normal renal function. J Cardiovasc Pharmacol. 2004;44:520–4.CrossRefPubMed

57.

Leoncini G, Martinoli C, Viazzi F, et al. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. Nephron. 2002;90:169–73.CrossRefPubMed

Titel: Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors
verfasst von: Yoshito Yamaguchi
Fuyuko Akagaki
Aya Nakamori
Toshihiro Sugiura
Publikationsdatum: 13.11.2018
Verlag: Springer Singapore
Erschienen in: Clinical and Experimental Nephrology / Ausgabe 4/2019
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-018-1667-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Anzeige

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen